Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-79.55%
End price
10.08.24
€3.66
Summary
This prediction ended on 10.08.24 with a price of €3.66. Piper_Sandler correctly predicted massive losses of -79.55% for Eagle Pharmaceuticals Inc. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 3.011% | 1.442% | 22.848% |
| iShares Nasdaq 100 | 3.009% | 0.574% | 37.061% |
| iShares Nikkei 225® | 4.142% | 4.547% | 53.856% |
| iShares S&P 500 | 2.378% | 0.244% | 29.012% |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat
In the thread Trading Eagle Pharmaceuticals Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten